Travere Therapeutics provides several forms of grant support

Our Investigator Sponsored Research (ISR) program supports research that can advance the collective understanding of our products and therapeutic focus, which may ultimately improve patient care. We encourage investigators to submit grant proposals that have this goal in mind.

Travere Therapeutics provides several forms of grant support, which may include:

  • Funding for expenses directly associated with research protocol-related study activities
  • Free clinical trial material for in-vitro and animal studies or clinical trial research; or
  • A combination of the above

Travere Therapeutics is committed to a rigorous process for awarding grants

As such, all accepted grant proposals are reviewed by the company’s multidisciplinary ISR Review Committee. Accepted grant proposals are evaluated thoroughly based on medical or scientific merit, as well as alignment to Travere Therapeutics’ overarching research goals.

Our Investigator Sponsored Research (ISR) Areas of Interest:

  • Studies of sparsentan in rare kidney disease (RKD)
  • Studies to assess quality of life for people with RKD
  • Biomarker and/or research science studies in RKD


Interested parties may submit either a concept review or full proposal outlining the proposed research and request for support. If interested in submitting a proposal, please click here:

Grants Portal

Upon approval of the full study protocol and budget, a research support agreement must be fully executed by the researcher, their institution, and Travere Therapeutics.

Any personal data you provide Travere Therapeutics will be processed according to our Privacy Policies.